| Name | Title | Contact Details |
|---|
Flex America is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EMINENT Services Corporation is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For 60 years, EveryMind has improved the mental health and wellness of children, youth, adults, and families in the National Capital Region. Based in Rockville, MD, EveryMinds dedicated staff of professionals and volunteers work to strengthen communi...
Truman Medical Centers (TMC) has all the things you expect from a great health system. With two, acute care academic hospital locations, a behavioral health program, a long term care facility and multiple primary care practices, TMC provides care from birth through your senior years. TMC Hospital Hill, in downtown Kansas City, is the busiest Level One Trauma Center in the city. From the healing environment of 400 works of museum quality art to our seasonal produce market, you can count on something special at TMC. We provide the full range of services with specialties in chronic disease management, high risk pregnancy and sleep disorders along with the brand new state of the art Richard and Annette Bloch Cancer Center. In eastern Jackson County, TMC Lakewood sits on 300 acres of beautiful wooded grounds, with a nature walking trail and scenic views, our facility is the epitome of comfort and care. We have all the services you would expect a community hospital from emergency medicine to a nationally-certified orthopaedic joint replacement program as well as a labor and delivery unit that provides comfort and care for the whole family. We have several community-based family medical care centers and a radiology center that provides the latest in technology and specialized breast cancer care that includes a board certified plastic and reconstructive surgeon close to home.
Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.